{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:03:13Z","timestamp":1781974993235,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":172,"publisher":"Springer US","isbn-type":[{"value":"9781461408864","type":"print"},{"value":"9781461408871","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-4614-0887-1_3","type":"book-chapter","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T09:37:07Z","timestamp":1331026627000},"page":"41-64","source":"Crossref","is-referenced-by-count":65,"title":["FGF23 and Syndromes of Abnormal Renal Phosphate Handling"],"prefix":"10.1007","author":[{"given":"Clemens","family":"Bergwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"3_CR1","first-page":"287","volume":"7","author":"JW Bianchine","year":"1971","unstructured":"Bianchine JW, Stambler AA, Harrison HE. Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser 1971; 7:287\u2013295.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","volume":"82","author":"MJ Econs","year":"1997","unstructured":"Econs MJ, McEnery PT. Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 1997; 82:674\u2013681.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI119809","volume":"100","author":"M Econs","year":"1997","unstructured":"Econs M, McEnery P, Lennon F et al. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 1997; 100:2653\u20132657.","journal-title":"J Clin Invest"},{"key":"3_CR4","doi-asserted-by":"crossref","unstructured":"ADHR Consortium T. White KE, Evans WE et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000; 26:345\u2013348.","DOI":"10.1038\/81664"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00774-009-0111-5","volume":"28","author":"M Gribaa","year":"2009","unstructured":"Gribaa M, Younes M, Bouyacoub Y et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 2009; 28:111\u2013115.","journal-title":"J Bone Miner Metab"},{"key":"3_CR6","first-page":"305","volume":"55","author":"K Kruse","year":"2001","unstructured":"Kruse K, Woelfel D, Strom TM. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation. Horm Res 2001; 55:305\u2013308.","journal-title":"Horm Res"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9343(64)90085-3","volume":"36","author":"CH Burnett","year":"1964","unstructured":"Burnett CH, Dent CE, Harper C et al. Vitamin D-resistant rickets. Analysis of twenty-four pedigrees with hereditary and sporadic cases. Am J Med 1964; 36:222\u2013232.","journal-title":"Am J Med"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0712361105","volume":"105","author":"CA Brownstein","year":"2008","unstructured":"Brownstein CA, Adler F, Nelson-Williams C et al. A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci USA 2008; 105:3455\u20133460.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","volume":"277","author":"T Yamashita","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000; 277:494\u2013498.","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SM Burnett","year":"2006","unstructured":"Burnett SM, Gunawardene SC, Bringhurst FR et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006; 21:1187\u20131196.","journal-title":"J Bone Miner Res"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","volume":"293","author":"F Perwad","year":"2007","unstructured":"Perwad F, Zhang MY, Tenenhouse HS et al. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 2007; 293:F1577\u2013F1583.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","volume":"69","author":"N Nagano","year":"2006","unstructured":"Nagano N, Miyata S, Abe M et al. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 2006; 69:531\u2013537.","journal-title":"Kidney Int"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","volume":"101","author":"H Nishi","year":"2005","unstructured":"Nishi H, Nii-Kono T, Nakanishi S et al. Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism. Nephron Clin Pract 2005; 101:c94\u2013c99.","journal-title":"Nephron Clin Pract"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","volume":"289","author":"OI Kolek","year":"2005","unstructured":"Kolek OI, Hines ER, Jones MD et al. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005; 289:G1036\u2013G1042.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","volume":"118","author":"LD Quarles","year":"2008","unstructured":"Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 2008; 118:3820\u20133828.","journal-title":"J Clin Invest"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 2002; 143:3179\u20133182.","journal-title":"Endocrinology"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","volume":"281","author":"K Kato","year":"2006","unstructured":"Kato K, Jeanneau C, Tarp MA et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 2006; 281:18370\u201318377.","journal-title":"J Biol Chem"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/jbmr.061105","volume":"22","author":"Y Frishberg","year":"2007","unstructured":"Frishberg Y, Ito N, Rinat C et al. Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. J Bone Miner Res 2007; 22:235\u2013242.","journal-title":"J Bone Miner Res"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbadis.2008.09.016","volume":"1792","author":"I Chefetz","year":"2009","unstructured":"Chefetz I, Kohno K, Izumi H et al. GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta 2009; 1792:61\u201367.","journal-title":"Biochim Biophys Acta"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 2001; 60:2079\u20132086.","journal-title":"Kidney Int"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Imel EA, Kreiter ML et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007; 117:2684\u20132691.","journal-title":"J Clin Invest"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390:45\u201351.","journal-title":"Nature"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1152\/ajpendo.90539.2008","volume":"296","author":"X Bai","year":"2009","unstructured":"Bai X, Dinghong Q, Miao D et al. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype. Am J Physiol Endocrinol Metab 2009; 296:E79\u2013E88.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu H, Yamamoto M, Clark JD et al. Suppression of aging in mice by the hormone Klotho. Science 2005; 309:1829\u20131833.","journal-title":"Science"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444:770\u2013774.","journal-title":"Nature"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, Tamada T, Kasai N et al. Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 2008; 23:1509\u20131518.","journal-title":"J Bone Miner Res"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 2006; 281:15694\u201315700.","journal-title":"J Biol Chem"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1744-9987.2005.00287.x","volume":"9","author":"X Yu","year":"2005","unstructured":"Yu X, White KE. Fibroblast growth factor 23 and its receptors. Ther Apher Dial 2005; 9:308\u2013312.","journal-title":"Ther Apher Dial"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"28265","DOI":"10.1074\/jbc.M202527200","volume":"277","author":"T Yamashita","year":"2002","unstructured":"Yamashita T, Konishi M, Miyake A et al. Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem 2002; 277:28265\u201328270.","journal-title":"J Biol Chem"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","volume":"295","author":"S Liu","year":"2008","unstructured":"Liu S, Zhou J, Tang W et al. Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab 2008; 295:E254\u2013E261.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"F769","DOI":"10.1152\/ajprenal.00248.2006","volume":"292","author":"H Segawa","year":"2007","unstructured":"Segawa H, Yamanaka S, Ohno Y et al. Correlation between hyperphosphatemia and type IINa-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 2007; 292:F769\u2013F779.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","volume":"68","author":"M Baum","year":"2005","unstructured":"Baum M, Schiavi S, Dwarakanath V et al. Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int 2005; 68:1148\u20131153.","journal-title":"Kidney Int"},{"key":"3_CR33","unstructured":"Segawa H, Onitsuka A, Aranami F et al. Npt2a and Npt2c in Mice Play Distinct and Synergistic Roles in Inorganic Phosphate Metabolism and Skeletal Development. RENAL WEEK 2006, San Francisco, 2007; pp abstract SA-FC101."},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MNH.0b013e3282fd6e5b","volume":"17","author":"TM Strom","year":"2008","unstructured":"Strom TM, J\u00fcppner H. PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 2008; 17:357\u2013362.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MNH.0b013e3281ca6ffd","volume":"16","author":"S Liu","year":"2007","unstructured":"Liu S, Gupta A, Quarles LD. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 2007; 16:329\u2013335.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bone.2006.12.062","volume":"40","author":"S Fukumoto","year":"2007","unstructured":"Fukumoto S, Yamashita T. FGF23 is a hormone-regulating phosphate metabolism\u2014unique biological characteristics of FGF23. Bone 2007; 40:1190\u20131195.","journal-title":"Bone"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","volume":"20","author":"EG Farrow","year":"2009","unstructured":"Farrow EG, Davis SI, Summers LJ et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 2009; 20:955\u2013960.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.1114245","volume":"310","author":"Q Chang","year":"2005","unstructured":"Chang Q, Hoefs S, van der Kemp AW et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005; 310:490\u2013493.","journal-title":"Science"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/mol.109.055780","volume":"76","author":"SK Cha","year":"2009","unstructured":"Cha SK, Hu MC, Kurosu H et al. Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol 2009; 76:38\u201346.","journal-title":"Mol Pharmacol"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.mad.2005.07.007","volume":"126","author":"H Masuda","year":"2005","unstructured":"Masuda H, Chikuda H, Suga T et al. Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech Ageing Dev 2005; 126:1274\u201312783.","journal-title":"Mech Ageing Dev"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1210\/en.2002-220454","volume":"143","author":"MM Donohue","year":"2002","unstructured":"Donohue MM, Demay MB. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 2002; 143:3691\u20133694.","journal-title":"Endocrinology"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/adc.84.6.501","volume":"84","author":"H Narchi","year":"2001","unstructured":"Narchi H, El Jamil M, Kulaylat N. Symptomatic rickets in adolescence. Arch Dis Child 2001; 84:501\u2013503.","journal-title":"Arch Dis Child"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0950-351X(97)80569-1","volume":"11","author":"RM Francis","year":"1997","unstructured":"Francis RM, Selby PL. Osteomalacia. Baillieres Clin Endocrinol Metab 1997; 11:145\u2013163.","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-6009(08)80127-4","volume":"24","author":"MJ Econs","year":"1994","unstructured":"Econs MJ, Samsa GP, Monger M et al. X-Linked hypophosphatemic rickets: a disease often unknown to affected patients. Bone Miner 1994; 24:17\u201324.","journal-title":"Bone Miner"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","volume":"85","author":"G Liang","year":"2009","unstructured":"Liang G, Katz LD, Insogna KL et al. Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 2009; 85:235\u2013246.","journal-title":"Calcif Tissue Int"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1010054727323","volume":"2","author":"LA DiMeglio","year":"2001","unstructured":"DiMeglio LA, Econs MJ. Hypophosphatemic rickets. Rev Endocr Metab Disord 2001; 2:165\u2013173.","journal-title":"Rev Endocr Metab Disord"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975; 2:309\u2013310.","journal-title":"Lancet"},{"key":"3_CR48","first-page":"163","volume":"17","author":"J Brodehl","year":"1982","unstructured":"Brodehl J, Gellissen K, Weber HP. Postnatal development of tubular phosphate reabsorption. Clin Nephrol 1982; 17:163\u2013171.","journal-title":"Clin Nephrol"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF00865491","volume":"8","author":"U Alon","year":"1994","unstructured":"Alon U, Hellerstein S. Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol 1994; 8:250\u2013251.","journal-title":"Pediatr Nephrol"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM198503073121003","volume":"312","author":"M Tieder","year":"1985","unstructured":"Tieder M, Modai D, Samuel R et al. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 1985; 312:611\u2013617.","journal-title":"N Engl J Med"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/508263","volume":"79","author":"A Corut","year":"2006","unstructured":"Corut A, Senyigit A, Ugur SA et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006; 79:650\u2013656.","journal-title":"Am J Hum Genet"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2008-1076716","volume":"117","author":"B Kremke","year":"2009","unstructured":"Kremke B, Bergwitz C, Ahrens W et al. 2009 Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3\/NaPi-IIc can be masked by vitamin D deficiency and can be associated with renal calcifications. Exp Clin Endocrinol Diabetes 117:49\u201356.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 2002; 87:4957\u20134960.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003; 348:1656\u20131663.","journal-title":"N Engl J Med"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K et al. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 2008; 42:1235\u20131239.","journal-title":"Bone"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P et al. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 2006; 91:2055\u20132061.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR57","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","volume":"22","author":"EA Imel","year":"2007","unstructured":"Imel EA, Hui SL, Econs MJ. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 2007; 22:520\u2013526.","journal-title":"J Bone Miner Res"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O, Shurman DL, Bergman R et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004; 36:579\u2013581.","journal-title":"Nat Genet"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2006-1825","volume":"92","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Guigonis V, Imel EA et al. Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 2007; 92:1943\u20131947.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1210\/jc.2004-2238","volume":"90","author":"T Larsson","year":"2005","unstructured":"Larsson T, Yu X, Davis SI et al. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 2005; 90:2424\u20132427.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","volume":"22","author":"JL Geller","year":"2007","unstructured":"Geller JL, Khosravi A, Kelly MH et al. Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 2007; 22:931\u2013937.","journal-title":"J Bone Miner Res"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","volume":"3","author":"US Alon","year":"2008","unstructured":"Alon US, Levy-Olomucki R, Moore WV et al. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol 2008; 3:658\u2013664.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1542\/peds.108.1.e6","volume":"108","author":"MG Seikaly","year":"2001","unstructured":"Seikaly MG, Baum M. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia. Pediatrics 2001; 108:E6.","journal-title":"Pediatrics"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","volume":"24","author":"Y Aono","year":"2009","unstructured":"Aono Y, Yamazaki Y, Yasutake J et al. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia. J Bone Miner Res 2009; 24:1879\u20131888.","journal-title":"J Bone Miner Res"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","volume":"2","author":"MK Drezner","year":"2001","unstructured":"Drezner MK. Tumor-induced osteomalacia. Rev Endocr Metab Disord 2001; 2:175\u2013186.","journal-title":"Rev Endocr Metab Disord"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98:6500\u20136505.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR67","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","volume":"90","author":"TO Carpenter","year":"2005","unstructured":"Carpenter TO, Ellis BK, Insogna KL et al. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 2005; 90:1012\u20131020.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","volume":"67","author":"PS Rowe","year":"2000","unstructured":"Rowe PS, de Zoysa PA, Dong R et al. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Genomics 2000; 67:54\u201368.","journal-title":"Genomics"},{"key":"3_CR69","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","volume":"17","author":"S Jan De Beur","year":"2002","unstructured":"Jan De Beur S, Finnegan R, Vassiliadis J et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 2002; 17:1102\u20131110.","journal-title":"J Bone Miner Res"},{"key":"3_CR70","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI18563","volume":"112","author":"T Berndt","year":"2003","unstructured":"Berndt T, Craig T, Bowe A et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 2003; 112:785\u2013794.","journal-title":"J Clin Invest"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","volume":"24","author":"BD Nguyen","year":"1999","unstructured":"Nguyen BD, Wang EA. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med 1999; 24:130\u2013131.","journal-title":"Clin Nucl Med"},{"key":"3_CR72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.revmed.2004.11.013","volume":"26","author":"JL Dupond","year":"2005","unstructured":"Dupond JL, Magy N, Mahammedi M et al. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient]. Rev Med Interne 2005; 26:238\u2013241.","journal-title":"Rev Med Interne"},{"key":"3_CR73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","volume":"22","author":"E Hesse","year":"2007","unstructured":"Hesse E, Moessinger E, Rosenthal H et al. Oncogenic osteomalacia: exact tumor localization by coregistration of positron emission and computed tomography. J Bone Miner Res 2007; 22:158\u2013162.","journal-title":"J Bone Miner Res"},{"key":"3_CR74","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","volume":"89","author":"Y Takeuchi","year":"2004","unstructured":"Takeuchi Y, Suzuki H, Ogura S et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004; 89:3979\u20133982.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR75","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4158\/EP.14.3.362","volume":"14","author":"PA Westerberg","year":"2008","unstructured":"Westerberg PA, Olauson H, Toss G et al. Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia. Endocr Pract 2008; 14:362\u2013367.","journal-title":"Endocr Pract"},{"key":"3_CR76","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2169\/internalmedicine.47.0745","volume":"47","author":"T Nasu","year":"2008","unstructured":"Nasu T, Kurisu S, Matsuno S et al. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. Intern Med 2008; 47:957\u2013961.","journal-title":"Intern Med"},{"key":"3_CR77","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-07-0779","volume":"158","author":"G Boekel van","year":"2008","unstructured":"van Boekel G, Ruinemans-Koerts J, Joosten F et al. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 2008; 158:431\u2013437.","journal-title":"Eur J Endocrinol"},{"key":"3_CR78","first-page":"356","volume":"12","author":"AM Parfitt","year":"1986","unstructured":"Parfitt AM, Kleerekoper M, Cruz C. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Miner Electrolyte Metab 1986; 12:356\u2013362.","journal-title":"Miner Electrolyte Metab"},{"key":"3_CR79","doi-asserted-by":"crossref","unstructured":"Levi M. Post-transplant hypophosphatemia. Kidney Int 59:2377\u20132387.","DOI":"10.1046\/j.1523-1755.2001.00755.x"},{"key":"3_CR80","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","volume":"70","author":"I Bhan","year":"2006","unstructured":"Bhan I, Shah A, Holmes J et al. Post-transplant hypophosphatemia: Tertiary \u201cHyper-Phosphatoninism\u201d? Kidney Int 2006; 70:1486\u20131494.","journal-title":"Kidney Int"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"p23","DOI":"10.1159\/000093277","volume":"104","author":"S Pande","year":"2006","unstructured":"Pande S, Ritter CS, Rothstein M et al. FGF-23 and sFRP-4 in chronic kidney disease and postrenal transplantation. Nephron Physiol 2006; 104:p23\u2013p32.","journal-title":"Nephron Physiol"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","volume":"92","author":"A Khosravi","year":"2007","unstructured":"Khosravi A, Cutler CM, Kelly MH et al. Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab 2007; 92:2374\u20132377.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR83","first-page":"395","volume":"143","author":"H Nordstrom","year":"1977","unstructured":"Nordstrom H, Lennquist S, Lindell B et al. Hypophosphataemia in severe burns. Acta Chir Scand 1977; 143:395\u2013399.","journal-title":"Acta Chir Scand"},{"key":"3_CR84","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0148607101025003152","volume":"25","author":"RN Dickerson","year":"2001","unstructured":"Dickerson RN, Gervasio JM, Sherman JJ et al. A comparison of renal phosphorus regulation in thermally injured and multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr 2001; 25:152\u2013159.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"3_CR85","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/SLA.0b013e31805d0882","volume":"245","author":"O Nafidi","year":"2007","unstructured":"Nafidi O, Lepage R, Lapointe RW et al. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg 2007; 245:1000\u20131002.","journal-title":"Ann Surg"},{"key":"3_CR86","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/SLA.0b013e3181a3e562","volume":"249","author":"O Nafidi","year":"2009","unstructured":"Nafidi O, Lapointe RW, Lepage R et al. Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia. Ann Surg 2009; 249:824\u2013827.","journal-title":"Ann Surg"},{"key":"3_CR87","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.sla.0000152093.43468.c0","volume":"241","author":"RR Salem","year":"2005","unstructured":"Salem RR, Tray K. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg 2005; 241:343\u2013348.","journal-title":"Ann Surg"},{"key":"3_CR88","first-page":"529","volume":"54","author":"F Albright","year":"1937","unstructured":"Albright F, Butler AM, Bloomberg E. Rickets resistant to vitamin D therapy Am J Dis Child 1937; 54 529\u2013547.","journal-title":"Am J Dis Child"},{"key":"3_CR89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005792-195805000-00001","volume":"37","author":"RW Winters","year":"1958","unstructured":"Winters RW, Graham JB, Williams TF et al. A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. Medicine (Baltimore) 1958; 37:97\u2013142.","journal-title":"Medicine (Baltimore)"},{"key":"3_CR90","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"HYP-Consortium","year":"1995","unstructured":"HYP-Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 1995; 11:130\u2013136.","journal-title":"Nat Genet"},{"key":"3_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-1004(200007)16:1<1::AID-HUMU1>3.0.CO;2-J","volume":"16","author":"Y Sabbagh","year":"2000","unstructured":"Sabbagh Y, Jones AO, Tenenhouse HS. PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia. Hum Mutat 2000; 16:1\u20136.","journal-title":"Hum Mutat"},{"key":"3_CR92","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","volume":"278","author":"S Liu","year":"2003","unstructured":"Liu S, Guo R, Simpson LG et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278:37419\u201337426.","journal-title":"J Biol Chem"},{"key":"3_CR93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004; 23:421\u2013432.","journal-title":"Matrix Biol"},{"key":"3_CR94","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18:1637\u20131647.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR95","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2007-1296","volume":"93","author":"P Makras","year":"2008","unstructured":"Makras P, Hamdy NA, Kant SG et al. Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX gene. J Clin Endocrinol Metab 2008; 93:1386\u20131389.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR96","first-page":"237","volume":"71","author":"CJ Owen","year":"2009","unstructured":"Owen CJ, Habeb A, Pearce SH et al. Discordance for X-linked hypophosphataemic rickets in identical twin girls. Horm Res 2009; 71:237\u2013244.","journal-title":"Horm Res"},{"key":"3_CR97","first-page":"1514","volume":"75","author":"SA Rivkees","year":"1992","unstructured":"Rivkees SA, el-Hajj-Fuleihan G, Brown EM et al. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 1992; 75:1514\u20131518.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR98","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1542\/peds.100.5.879","volume":"100","author":"MG Seikaly","year":"1997","unstructured":"Seikaly MG, Brown R, Baum M. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics 1997; 100:879\u2013884.","journal-title":"Pediatrics"},{"key":"3_CR99","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Bastepe M, Benet-Pages A et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006; 38:1248\u20131250.","journal-title":"Nat Genet"},{"key":"3_CR100","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006; 38:1310\u20131315.","journal-title":"Nat Genet"},{"key":"3_CR101","doi-asserted-by":"crossref","unstructured":"Levy-Litan V, Hershkovitz E, Avizov L et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 86:273\u2013278.","DOI":"10.1016\/j.ajhg.2010.01.010"},{"key":"3_CR102","doi-asserted-by":"crossref","unstructured":"Lorenz-Depiereux B, Schnabel D, Tiosano D et al. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 86:267\u2013272.","DOI":"10.1016\/j.ajhg.2010.01.006"},{"key":"3_CR103","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.M804283200","volume":"283","author":"Z Marschall von","year":"2008","unstructured":"von Marschall Z, Fisher LW. Dentin matrix protein-1 isoforms promote differential cell attachment and migration. J Biol Chem 2008; 283:32730\u201332740.","journal-title":"J Biol Chem"},{"key":"3_CR104","first-page":"16","volume":"23","author":"B Yuan","year":"2008","unstructured":"Yuan B, Meudt J, Feng JO et al. 7B2 protein mediated inhibition of DMP1 cleavage in osteoblasts enhances FGF-23 production in hyp-mice. JBMR 2008; 23:s16 (abstract 1053).","journal-title":"JBMR"},{"key":"3_CR105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000151727","volume":"189","author":"Y Lu","year":"2009","unstructured":"Lu Y, Qin C, Xie Y et al. Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells Tissues Organs 2009; 189:175\u2013185.","journal-title":"Cells Tissues Organs"},{"key":"3_CR106","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11302-005-5304-3","volume":"2","author":"R Terkeltaub","year":"2006","unstructured":"Terkeltaub R. Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase\/phosphodiesterase family focusing on NPP1 in calcification. Purinergic Signal 2006; 2:371\u2013377.","journal-title":"Purinergic Signal"},{"key":"3_CR107","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9440(10)63996-X","volume":"158","author":"F Rutsch","year":"2001","unstructured":"Rutsch F, Vaingankar S, Johnson K et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001; 158:543\u2013554.","journal-title":"Am J Pathol"},{"key":"3_CR108","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng1221","volume":"34","author":"F Rutsch","year":"2003","unstructured":"Rutsch F, Ruf N, Vaingankar S et al. Mutations in ENPP1 are associated with \u201cidiopathic\u201d infantile arterial calcification. Nat Genet 2003; 34:379\u2013381.","journal-title":"Nat Genet"},{"key":"3_CR109","first-page":"167","volume":"5","author":"KA Ramjan","year":"2009","unstructured":"Ramjan KA, Roscioli T, Rutsch F et al. Generalized arterial calcification of infancy: treatment with bisphosphonates. Nat Clin Pract Endocrinol Metab 2009; 5:167\u2013172.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"3_CR110","first-page":"280","volume":"46","author":"BN Chodirker","year":"1990","unstructured":"Chodirker BN, Evans JA, Seargeant LE et al. Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening. Am J Hum Genet 1990; 46:280\u2013285.","journal-title":"Am J Hum Genet"},{"key":"3_CR111","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V123507","volume":"12","author":"A Jones","year":"2001","unstructured":"Jones A, Tzenova J, Frappier D et al. Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na\/Pi cotransporter NPT2 gene. J Am Soc Nephrol 2001; 12:507\u2013514.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR112","first-page":"5039","volume-title":"The Metabolic and Molecular Bases of Inherited Diseases","author":"HS Tenenhouse","year":"2001","unstructured":"Tenenhouse HS, Econs MJ. Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Vogelstein B, Childs B, Kinzler KW, eds. The Metabolic and Molecular Bases of Inherited Diseases, 8th ed. McGraw-Hill, New York; 2001; pp 5039\u20135067.","edition":"8"},{"key":"3_CR113","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Benet-Pages A, Eckstein G et al. Hereditary Hypophosphatemic Rickets with Hypercalciuria Is Caused by Mutations in the Sodium-Phosphate Cotransporter Gene SLC34A3. Am J Hum Genet 2006; 78:193\u2013201.","journal-title":"Am J Hum Genet"},{"key":"3_CR114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"Bergwitz C, Roslin NM, Tieder M et al. SLC34A3 Mutations in Patients with Hereditary Hypophosphatemic Rickets with Hypercalciuria Predict a Key Role for the Sodium-Phosphate Cotransporter NaPi-IIc in Maintaining Phosphate Homeostasis. Am J Hum Genet 2006; 78:179\u2013192.","journal-title":"Am J Hum Genet"},{"key":"3_CR115","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1210\/jc.2005-2840","volume":"91","author":"S Ichikawa","year":"2006","unstructured":"Ichikawa S, Sorenson AH, Imel EA et al. Intronic Deletions in the SLC34A3 Gene Cause Hereditary Hypophosphatemic Rickets with Hypercalciuria. J Clin Endocrinol Metab 2006; 91:4022\u20134027.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR116","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00090.2008","volume":"295","author":"G Jaureguiberry","year":"2008","unstructured":"Jaureguiberry G, Carpenter TO, Forman S et al. A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc. Am J Physiol Renal Physiol 2008; 295:F371\u2013F379.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3_CR117","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"D Prie","year":"2002","unstructured":"Prie D, Huart V, Bakouh N et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 2002; 347:983\u2013991.","journal-title":"N Engl J Med"},{"key":"3_CR118","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/sj.ki.5000437","volume":"69","author":"JY Lapointe","year":"2006","unstructured":"Lapointe JY, Tessier J, Paquette Y et al. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 2006; 69:2261\u20132267.","journal-title":"Kidney Int"},{"key":"3_CR119","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1359\/jbmr.2003.18.12.2135","volume":"18","author":"LV Virkki","year":"2003","unstructured":"Virkki LV, Forster IC, Hernando N et al. Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa. J Bone Miner Res 2003; 18:2135\u20132141.","journal-title":"J Bone Miner Res"},{"key":"3_CR120","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0802836","volume":"359","author":"Z Karim","year":"2008","unstructured":"Karim Z, Gerard B, Bakouh N et al. NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 2008; 359:1128\u20131135.","journal-title":"N Engl J Med"},{"key":"3_CR121","first-page":"2615","volume":"359","author":"C Bergwitz","year":"2008","unstructured":"Bergwitz C, Bastepe M. NHERF1 Mutations and Responsiveness of Renal Parathyroid Hormone. NEJM 2008; 359:2615\u20132617.","journal-title":"NEJM"},{"key":"3_CR122","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM198809293191307","volume":"319","author":"M Tieder","year":"1988","unstructured":"Tieder M, Arie R, Modai D et al. Elevated serum 1,25-dihydroxyvitamin D concentrations in siblings with primary Fanconi\u2019s syndrome. N Engl J Med 1988; 319:845\u2013849.","journal-title":"N Engl J Med"},{"key":"3_CR123","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","volume":"362","author":"D Magen","year":"2010","unstructured":"Magen D, Berger L, Coady MJ et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi\u2019s syndrome. N Engl J Med 2010; 362:1102\u20131109.","journal-title":"N Engl J Med"},{"key":"3_CR124","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","volume":"95","author":"L Beck","year":"1998","unstructured":"Beck L, Karaplis AC, Amizuka N et al. Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria and skeletal abnormalities. Proc Natl Acad Sci USA 1998; 95:5372\u20135377.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR125","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1681\/ASN.2007121360","volume":"19","author":"T Iwaki","year":"2008","unstructured":"Iwaki T, Sandoval-Cooper MJ, Tenenhouse HS et al. A missense mutation in the sodium phosphate cotransporter Slc34a1 impairs phosphate homeostasis. J Am Soc Nephrol 2008; 19:1753\u20131762.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01644343","volume":"10","author":"P Beighton","year":"1980","unstructured":"Beighton P, Cremin BJ, Kozlowski K. Osteoglophonic dwarfism. Pediatr Radiol 1980; 10:46\u201350.","journal-title":"Pediatr Radiol"},{"key":"3_CR127","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1096-8628(19961211)66:2<154::AID-AJMG6>3.0.CO;2-R","volume":"66","author":"S Sklower Brooks","year":"1996","unstructured":"Sklower Brooks S, Kassner G, Qazi Q et al. Osteoglophonic dysplasia: review and further delineation of the syndrome. Am J Med Genet 1996; 66:154\u2013162.","journal-title":"Am J Med Genet"},{"key":"3_CR128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","volume":"76","author":"KE White","year":"2005","unstructured":"White KE, Cabral JM, Davis SI et al. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet 2005; 76:361\u2013367.","journal-title":"Am J Hum Genet"},{"key":"3_CR129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ajmg.a.31106","volume":"140","author":"EG Farrow","year":"2006","unstructured":"Farrow EG, Davis SI, Mooney SD et al. Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am J Med Genet A 2006; 140:537\u2013539.","journal-title":"Am J Med Genet A"},{"key":"3_CR130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.1320190117","volume":"19","author":"P Maroteaux","year":"1984","unstructured":"Maroteaux P, Stanescu V, Stanescu R et al. Opsismodysplasia: a new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebrae. Am J Med Genet 1984; 19:171\u2013182.","journal-title":"Am J Med Genet"},{"key":"3_CR131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/JPEM.2007.20.1.79","volume":"20","author":"MD Zeger","year":"2007","unstructured":"Zeger MD, Adkins D, Fordham LA et al. Hypophosphatemic rickets in opsismodysplasia. J Pediatr Endocrinol Metab 2007; 20:79\u201386.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3_CR132","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.1968.01610090045007","volume":"97","author":"LM Solomon","year":"1968","unstructured":"Solomon LM, Fretzin DF, Dewald RL. The epidermal nevus syndrome. Arch Dermatol 1968; 97:273\u2013285.","journal-title":"Arch Dermatol"},{"key":"3_CR133","first-page":"139","volume":"120","author":"SS Gellis","year":"1970","unstructured":"Gellis SS, Feingold M. Linear nevus sebaceous syndrome. Am J Dis Child 1970; 120:139\u2013140.","journal-title":"Am J Dis Child"},{"key":"3_CR134","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1525-1470.1992.tb00623.x","volume":"9","author":"M Rogers","year":"1992","unstructured":"Rogers M. Epidermal nevi and the epidermal nevus syndromes: a review of 233 cases. Pediatr Dermatol 1992; 9:342\u2013344.","journal-title":"Pediatr Dermatol"},{"key":"3_CR135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pediatrneurol.2007.10.012","volume":"38","author":"S Menascu","year":"2008","unstructured":"Menascu S, Donner EJ. Linear nevus sebaceous syndrome: case reports and review of the literature. Pediatr Neurol 2008; 38:207\u2013210.","journal-title":"Pediatr Neurol"},{"key":"3_CR136","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI28163","volume":"116","author":"C Hafner","year":"2006","unstructured":"Hafner C, van Oers JM, Vogt T et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006; 116:2201\u20132207.","journal-title":"J Clin Invest"},{"key":"3_CR137","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0022-3476(87)80204-4","volume":"111","author":"F Skovby","year":"1987","unstructured":"Skovby F, Svejgaard E, Moller J. Hypophosphatemic rickets in linear sebaceous nevus sequence. J Pediatr 1987; 111:855\u2013857.","journal-title":"J Pediatr"},{"key":"3_CR138","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000070948","volume":"207","author":"M Zutt","year":"2003","unstructured":"Zutt M, Strutz F, Happle R et al. Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets. Dermatology 2003; 207:72\u201376.","journal-title":"Dermatology"},{"key":"3_CR139","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.a.30599","volume":"134","author":"WH Hoffman","year":"2005","unstructured":"Hoffman WH, J\u00fcppner HW, Deyoung BR et al. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. Am J Med Genet A 2005; 134:233\u2013236.","journal-title":"Am J Med Genet A"},{"key":"3_CR140","first-page":"611","volume":"42","author":"M John","year":"2005","unstructured":"John M, Shah NS. Hypophosphatemic rickets with epidermal nevus syndrome. Indian Pediatr 2005; 42:611\u2013612.","journal-title":"Indian Pediatr"},{"key":"3_CR141","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/ajmg.a.32395","volume":"146A","author":"WH Hoffman","year":"2008","unstructured":"Hoffman WH, Jain A, Chen H et al. Matrix extracellular phosphoglycoprotein (MEPE) correlates with serum phosphorus prior to and during octreotide treatment and following excisional surgery in hypophosphatemic linear sebaceous nevus syndrome. Am J Med Genet A 2008; 146A:2164\u20132168.","journal-title":"Am J Med Genet A"},{"key":"3_CR142","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1073\/pnas.89.11.5152","volume":"89","author":"WF Schwindinger","year":"1992","unstructured":"Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 1992; 89:5152\u20135156.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR143","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl J Med 1991; 325:1688\u20131695.","journal-title":"New Engl J Med"},{"key":"3_CR144","first-page":"675","volume":"22","author":"L Weinstein","year":"2001","unstructured":"Weinstein L, Yu S, Warner D et al. Endocrine Manifestations of Stimulatory G Protein alpha-Subunit Mutations and the Role of Genomic Imprinting. Endocr Rev 2001; 22:675\u2013705","journal-title":"Endocr Rev"},{"key":"3_CR145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s007740170012","volume":"19","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto T, Miyamoto KI, Ozono K et al. Hypophosphatemic rickets accompanying McCune-Albright syndrome: evidence that a humoral factor causes hypophosphatemia. J Bone Miner Metab 2001; 19:287\u2013295.","journal-title":"J Bone Miner Metab"},{"key":"3_CR146","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112:683\u2013692.","journal-title":"J Clin Invest"},{"key":"3_CR147","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1359\/jbmr.2001.16.5.806","volume":"16","author":"MT Collins","year":"2001","unstructured":"Collins MT, Chebli C, Jones J et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001; 16:806\u2013813.","journal-title":"J Bone Miner Res"},{"key":"3_CR148","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","volume":"78","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 2006; 78:2295\u20132301.","journal-title":"Life Sci"},{"key":"3_CR149","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","volume":"94","author":"WW Brown","year":"2009","unstructured":"Brown WW, J\u00fcppner H, Langman CB et al. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen\u2019s metaphyseal chondrodysplasia. J Clin Endocrinol Metab 2009; 94:17\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR150","first-page":"429","volume":"54","author":"YS Haviv","year":"2000","unstructured":"Haviv YS, Silver J. Late onset oncogenic osteomalacia-associated with neurofibromatosis type II. Clin Nephrol 2000; 54:429\u2013430.","journal-title":"Clin Nephrol"},{"key":"3_CR151","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000441-199105000-00006","volume":"301","author":"K Konishi","year":"1991","unstructured":"Konishi K, Nakamura M, Yamakawa H et al. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 1991; 301:322\u2013328.","journal-title":"Am J Med Sci"},{"key":"3_CR152","first-page":"1013","volume":"34","author":"JM Giard","year":"1998","unstructured":"Giard JM. Sur la calcifcation hibernale. Compes Rend Seanes Soc Biol So 1998; 34:1013\u20131015.","journal-title":"Compes Rend Seanes Soc Biol So"},{"key":"3_CR153","first-page":"725","volume":"74","author":"MH Duret","year":"1899","unstructured":"Duret MH. Tumeurs multiples et singulieres des bourses sereuses. Bull Mem Soc Ant Paris 1899; 74:725\u2013731.","journal-title":"Bull Mem Soc Ant Paris"},{"key":"3_CR154","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","volume":"4","author":"D Sitara","year":"2008","unstructured":"Sitara D, Kim S, Razzaque MS et al. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 2008; 4:e1000154.","journal-title":"PLoS Genet"},{"key":"3_CR155","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/en.2007-1205","volume":"149","author":"A Martin","year":"2008","unstructured":"Martin A, David V, Laurence JS et al. Degradation of MEPE, DMP1 and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 2008; 149:1757\u20131772.","journal-title":"Endocrinology"},{"key":"3_CR156","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2004-2302","volume":"90","author":"S Ichikawa","year":"2005","unstructured":"Ichikawa S, Lyles KW, Econs MJ. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab 2005; 90:2420\u20132423.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR157","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","volume":"83","author":"Y Frishberg","year":"2005","unstructured":"Frishberg Y, Topaz O, Bergman R et al. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med 2005; 83:33\u201338.","journal-title":"J Mol Med"},{"key":"3_CR158","unstructured":"Frishberg Y, Araya K, Rinat C et al. Sprecher E Hyperostosis-hyperphosphatemia syndrome caused by mutations in GALNT3 and associated with augmented processing of FGF-23. American Society of Nephrology, Philadelphia 2004; F\u2013P0937."},{"key":"3_CR159","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM et al. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 2005; 14:385\u2013390.","journal-title":"Hum Mol Genet"},{"key":"3_CR160","unstructured":"Masi L, Gozzini A, Carbonell S et al. A novel recessive mutation in fibroblast growth factor-23 (FGF23) causes a tumoral calcinosis. J Bone Miner Res 2005; p S128."},{"key":"3_CR161","doi-asserted-by":"crossref","first-page":"E929","DOI":"10.1152\/ajpendo.90456.2008","volume":"295","author":"HJ Garringer","year":"2008","unstructured":"Garringer HJ, Malekpour M, Esteghamat F et al. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 2008; 295:E929\u2013E937.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3_CR162","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113:561\u2013568.","journal-title":"J Clin Invest"},{"key":"3_CR163","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","volume":"26","author":"M Hesse","year":"2007","unstructured":"Hesse M, Fr\u00f6hlich LF, Zeitz U et al. Ablation of vitamin D signaling rescues bone, mineral and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 2007; 26:75\u201384.","journal-title":"Matrix Biol"},{"key":"3_CR164","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/en.2008-0877","volume":"150","author":"S Ichikawa","year":"2009","unstructured":"Ichikawa S, Sorenson AH, Austin AM et al. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 2009; 150:2543\u20132550.","journal-title":"Endocrinology"},{"key":"3_CR165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.05-5432fje","volume":"20","author":"MS Razzaque","year":"2006","unstructured":"Razzaque MS, Sitara D, Taguchi T et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006; 20:720\u2013722.","journal-title":"FASEB J"},{"key":"3_CR166","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ki.2009.24","volume":"75","author":"M Ohnishi","year":"2009","unstructured":"Ohnishi M, Nakatani T, Lanske B et al. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 2009; 75:1166\u20131172.","journal-title":"Kidney Int"},{"key":"3_CR167","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","volume":"18","author":"JR Stubbs","year":"2007","unstructured":"Stubbs JR, Liu S, Tang W et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin d in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18:2116\u20132124.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR168","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","volume":"291","author":"S Liu","year":"2006","unstructured":"Liu S, Zhou J, Tang W et al. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 2006; 291:E38\u2013E49.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4 Suppl","key":"3_CR169","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1016\/S8756-3282(95)80001-8","volume":"16","author":"T Yamaguchi","year":"1995","unstructured":"Yamaguchi T, Sugimoto T, Imai Y et al. Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone 1995; 16(4 Suppl):247S\u2013250S.","journal-title":"Bone"},{"key":"3_CR170","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1210\/jcem-50-4-648","volume":"50","author":"EG Lufkin","year":"1980","unstructured":"Lufkin EG, Wilson DM, Smith LH et al. Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide. J Clin Endocrinol Metab 1980; 50:648\u2013653.","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR171","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI9038","volume":"105","author":"M Gowen","year":"2000","unstructured":"Gowen M, Stroup GB, Dodds RA et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 2000; 105:1595\u20131604.","journal-title":"J Clin Invest"},{"key":"3_CR172","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1210\/jc.2009-0961","volume":"94","author":"C Bergwitz","year":"2009","unstructured":"Bergwitz C, Banerjee S, Abu-Zahra H et al. Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab 2009; 94:4267\u20134274.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Advances in Experimental Medicine and Biology","Endocrine FGFs and Klothos"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-0887-1_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:01:29Z","timestamp":1641052889000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-0887-1_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781461408864","9781461408871"],"references-count":172,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-0887-1_3","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}